Medical Engineering and Development Institute: FDA filings under this applicant name
FDA lists 6 510(k) clearances under the applicant name “Medical Engineering and Development Institute” (first 1989, latest 1990), across 5 product codes in 3 review panels. Median 510(k) review time under this name: 72 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| GCC | Dilator, Catheter | 2 | 2 |
| DRE | Dilator, Vessel, For Percutaneous Catheterization | 1 | 1 |
| DYB | Introducer, Catheter | 1 | 1 |
| GAD | Retractor | 1 | 1 |
| LJT | Port & Catheter, Implanted, Subcutaneous, Intravascular | 1 | 1 |
Review panels
Most recent Medical Engineering and Development Institute 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K902477 | WORKSTATION FEMORAL INTRAVASCULAR RETRIEVAL SET | DYB | 1990-08-24 | 81 |
| K902469 | BYRD DILATOR SHEATH SET - TEFLON | DRE | 1990-08-23 | 80 |
| K902502 | BYRD STAINLESS STEEL DILATOR | GCC | 1990-08-07 | 63 |
| K895030 | LIFE-LINE(TM) VASCULAR ACCESS SYSTEM | LJT | 1990-04-17 | 252 |
| K893480 | BYRD EXTRACTOR SET | GCC | 1989-06-23 | 50 |
| K890820 | LOCKING WIRE GUIDE STYLET | GAD | 1989-03-22 | 33 |
Recalls
openFDA lists no recalls under a recalling firm named Medical Engineering and Development Institute.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Medical Analysis Systems, Inc. (107 510(k)s)
- Medical Components, Inc. (63 510(k)s)
- Medical Advances, Inc. (57 510(k)s)
- Medical Diagnostic Technologies, Inc. (57 510(k)s)
- Medical Devices, Inc. (49 510(k)s)
- Medical Device Technologies, Inc. (46 510(k)s)
- Medical Specialties, Inc. (40 510(k)s)
- Medical Device Inspection Co., Inc. (30 510(k)s)
- Medical Engineering Corp. (28 510(k)s)
- Medical Data Electronics (27 510(k)s)
- Medical Graphics Corp. (25 510(k)s)
- Medical Innovations Corp. (24 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Medical Engineering and Development Institute?
FDA lists 6 510(k) clearances under the applicant name “Medical Engineering and Development Institute” (first 1989, latest 1990), across 5 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Medical Engineering and Development Institute?
The median time from FDA receipt to decision across 510(k)s cleared under the name Medical Engineering and Development Institute is 72 days.
Which FDA product codes appear under Medical Engineering and Development Institute?
The most frequent FDA product codes under this applicant name are GCC (Dilator, Catheter, 2); DRE (Dilator, Vessel, For Percutaneous Catheterization, 1); DYB (Introducer, Catheter, 1).
Next steps
- See all 6 Medical Engineering and Development Institute clearances with predicates and recalls
- Run predicate analysis for product code GCC, Medical Engineering and Development Institute's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.